The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Hospira beat expectations on revenues and beat slightly on earnings per share.
Compared to the prior-year quarter, revenue expanded and GAAP earnings per share grew.
Gross margins grew, operating margins shrank, net margins grew.
Hospira logged revenue of $1.10 billion. The 11 analysts polled by S&P Capital IQ expected a top line of $1.04 billion on the same basis. GAAP reported sales were 8.4% higher than the prior-year quarter's $1.01 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.55. The 15 earnings estimates compiled by S&P Capital IQ predicted $0.54 per share. GAAP EPS were $0.03 for Q4 versus -$1.30 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 28.6%, 60 basis points better than the prior-year quarter. Operating margin was 4.7%, 20 basis points worse than the prior-year quarter. Net margin was 0.5%, 2,160 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $1.01 billion. On the bottom line, the average EPS estimate is $0.51.
Next year's average estimate for revenue is $4.21 billion. The average EPS estimate is $2.30.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 130 members out of 156 rating the stock outperform, and 26 members rating it underperform. Among 46 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 38 give Hospira a green thumbs-up, and eight give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Hospira is hold, with an average price target of $33.32.
- Add Hospira to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.